Infosys Limited (INFY) Partners with Sentara To Enable AI Integration and Use in Hospitals

Neha Gupta

Wed, July 8, 2026 at 8:51 AM PDT 2 min read

Infosys Limited (NYSE:INFY) is one of the best beaten-down technology stocks to buy now. On June 24, Infosys Ltd (NYSE: INFY) entered into a strategic collaboration with Sentara to build a foundation for AI development across hospital operations, IT, and clinical support. The ultimate goal is to enhance efficiency, support clinicians, and improve the experiences of patients and members.

Infosys is to deploy its Topaz Fabric platform, a purpose-built agentic services suite, to help Sentara scale AI use cases from pilot programs to full production across enterprise systems. The approach will also help the not-for-profit healthcare organization prioritize high-value use cases, scale successful pilots, and evolve AI capabilities across business operations.

According to Venky Ananth, EVP and Global Head, Healthcare at Infosys, the strategic collaboration with Sentara will help unlock AI value by building a strong enterprise AI foundation. It will also accelerate operationalizing across hospital systems, leading to real efficiency gains for patients.

Infosys Limited (NYSE:INFY) is a global technology consulting, IT services, and digital transformation company. They help businesses across 59 countries modernize their operations by building custom software, migrating to the cloud (Infosys Cobalt), integrating generative AI (Infosys Topaz), and managing everyday tech systems.

While we acknowledge the potential of INFY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Dividend Stocks Yielding at Least 5% to Buy According to Hedge Funds and Top 10 Stocks to Buy According to Ariel Investments.

Disclosure: None. Follow Insider Monkey on Google News.